Actavis Renews Barclays ATP Finals Deal
After a first foray into tennis in 2013, Actavis has renewed its partnership with the Barclays ATP World Tour Finals for a further two years.
As part of the deal, Actavis will hold a strong courtside presence at The O2 in London where the top eight players in the world play for the trophy at the year-end climax to the men’s professional tennis season.
Lars Ramneborn, Senior Vice President Pharma Division International, said: ‘Our 2013 partnership was a great success. The Barclays ATP World Tour Finals enjoyed a record global TV audience and we are convinced that the tennis season finale, with its impressive roster of stars, provides an excellent platform for presenting our brand identity to viewers around the world and the spectators at the tournament.’
Laurent Delanney, commercial director of the ATP, added: ‘We are delighted to extend our partnership with Actavis, an industry leader in the world of pharmaceuticals.’
‘The variety and international scope of our partners continues to demonstrate the global appeal of our sport and our ability to deliver resounding value to our partners and their stakeholders.’
